This grant opportunity from the FDA focuses on the synthesis and biological activity assessment of different diastereomers in the siRNA drug LEQVIO (Inclisiran). The project aims to further research in this area, but clinical trials are not allowed under this funding.
Line Items
Item
Qty
Unit
Est. Unit Price
Est. Total
Category
Synthesis of LEQVIO (Inclisiran) Diastereomers
1
lot
$300,000.00
$300,000.00
Medical
Biological Activity Assessment of LEQVIO (Inclisiran) Diastereomers
1
lot
$400,000.00
$400,000.00
Medical
Data Analysis and Reporting
1
lot
$150,000.00
$150,000.00
Professional Services
Project Management
1
lot
$150,000.00
$150,000.00
Professional Services
Estimated Bid Value
$1,000,000.00
Want the full details?
Sign up free to see the agency name, contact info, and the original bid posting link.